医学
菌血症
重症监护医学
败血症
传染病(医学专业)
心内膜炎
感染性心内膜炎
疾病
头孢吡肟
抗生素
脑膜炎
内科学
儿科
抗生素耐药性
亚胺培南
微生物学
生物
作者
Amena Alhammadi,Rasha Alshawaf,Swati Chavda,Sonya Ramondino,Mindy G. Schuster
摘要
In 2023, published research on COVID-19 remains prominent. The aim of this article is to highlight important developments in infectious disease evidence unrelated to COVID-19 that were published in 2023. The literature was screened for sound new evidence relevant to internal medicine specialists and subspecialists whose focus of practice is not infectious diseases. The highlighted publications relate to various organisms and patient populations. One article provides insight into the updated guidelines for the diagnosis and management of infective endocarditis. Several articles address the management of sepsis and bacteremia: comparison of cefepime versus piperacillin-tazobactam, ceftobiprole for the treatment of complicated
科研通智能强力驱动
Strongly Powered by AbleSci AI